Recro Gainsville, a contract development and manufacturing organization and a wholly owned subsidiary of the specialty pharmaceutical company, Recro Pharma, Inc, has expanded its capabilities by adding a new tablet manufacturing suite and growing its development team. An FDA- and DEA-approved provider of solid oral dose manufacturing services for the pharmaceutical industry, Recro specializes in extended-release and controlled substances.

he company’s new suite includes a tablet press, the Fette FE 55, and a new film coater, the Bohle BTC-100.

Source: Recro Gainsville